JP2020512375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512375A5 JP2020512375A5 JP2019553504A JP2019553504A JP2020512375A5 JP 2020512375 A5 JP2020512375 A5 JP 2020512375A5 JP 2019553504 A JP2019553504 A JP 2019553504A JP 2019553504 A JP2019553504 A JP 2019553504A JP 2020512375 A5 JP2020512375 A5 JP 2020512375A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- cancer
- epitope
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762477895P | 2017-03-28 | 2017-03-28 | |
| US62/477,895 | 2017-03-28 | ||
| PCT/US2018/024831 WO2018183488A1 (en) | 2017-03-28 | 2018-03-28 | Human pd1 peptide vaccines and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512375A JP2020512375A (ja) | 2020-04-23 |
| JP2020512375A5 true JP2020512375A5 (cg-RX-API-DMAC7.html) | 2021-05-06 |
| JP7346302B2 JP7346302B2 (ja) | 2023-09-19 |
Family
ID=63678120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553504A Active JP7346302B2 (ja) | 2017-03-28 | 2018-03-28 | ヒトpd-1ペプチドワクチン及びその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11684660B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3600398B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7346302B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102653567B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN110636855B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2018243920B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019020386A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3058393A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2963635T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2019131252A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018183488A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021512966A (ja) * | 2018-02-07 | 2021-05-20 | イミュジーン、リミテッドImugene Limited | ワクチン組成物およびその使用 |
| WO2020071869A1 (ko) * | 2018-10-05 | 2020-04-09 | 알엔에이진 주식회사 | 표적 세포 특이적으로 결합하여 다중 면역기능이 강화된 키메라항원 및 이의용도 |
| BR112022005044A2 (pt) | 2019-09-17 | 2022-07-05 | Ohio State Innovation Foundation | Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento |
| WO2023205796A2 (en) * | 2022-04-21 | 2023-10-26 | Ohio State Innovation Foundation | Human ctla-4 peptide vaccines and uses thereof |
| WO2024211745A1 (en) * | 2023-04-05 | 2024-10-10 | Ohio State Innovation Foundation | Human pd1, pd-l1, and ctla-4 combination peptide vaccines and uses thereof |
| CN119019569B (zh) * | 2024-08-19 | 2025-10-24 | 中国人民解放军陆军军医大学 | 一种可定向增强胸腺新生t细胞杀伤乳腺癌的多肽及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (cg-RX-API-DMAC7.html) | 1968-10-17 | 1970-08-24 | ||
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US5652138A (en) | 1992-09-30 | 1997-07-29 | The Scripps Research Institute | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| CA2163032C (en) | 1993-06-03 | 2001-02-06 | John Landon | Antibody fragments in therapy |
| CN1215404A (zh) * | 1996-04-03 | 1999-04-28 | 佩普里瑟奇公司 | 非树状骨架肽载体 |
| FR2765243B1 (fr) | 1997-06-30 | 1999-07-30 | Usinor | Acier inoxydable austenoferritique a tres bas nickel et presentant un fort allongement en traction |
| CA2534060C (en) * | 2003-07-30 | 2012-06-12 | Vaccine Research Institute Of San Diego | Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| GB0400440D0 (en) * | 2004-01-09 | 2004-02-11 | Isis Innovation | Receptor modulators |
| EP3530736A3 (en) | 2005-05-09 | 2019-11-06 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| EP1912680B1 (en) | 2005-06-15 | 2014-11-26 | The Ohio State University Research Foundation | Her-2 peptides |
| NZ582823A (en) * | 2007-07-27 | 2012-04-27 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| WO2010011315A2 (en) * | 2008-07-25 | 2010-01-28 | Viral Genetics, Inc. | Proteins for use in diagnosing and treating infection and disease |
| US20100234283A1 (en) * | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| US8907053B2 (en) * | 2010-06-25 | 2014-12-09 | Aurigene Discovery Technologies Limited | Immunosuppression modulating compounds |
| RU2623161C2 (ru) * | 2011-04-15 | 2017-06-22 | Компуджен Лтд. | Полипептиды и полинуклеотиды и их применение для лечения иммунологических нарушений и рака |
| EP2744830A4 (en) * | 2012-06-21 | 2015-06-17 | Compugen Ltd | LSR ANTIBODIES AND USES THEREOF FOR THE TREATMENT OF CANCER |
| CA2884704C (en) * | 2012-09-07 | 2023-04-04 | Randolph J. Noelle | Vista modulators for diagnosis and treatment of cancer |
| WO2014161509A1 (en) * | 2013-04-05 | 2014-10-09 | The University Of Hong Kong | Novel pd1 isoforms, and uses thereof for potentiating immune responses |
| DK2992020T3 (da) * | 2013-05-03 | 2020-02-10 | Ohio State Innovation Foundation | Cs1-specifik kimær antigenreceptor-manipulerede immuneffektorceller |
| TWI676636B (zh) * | 2013-07-12 | 2019-11-11 | Vlp醫療股份有限公司 | 包含pd-1抗原或pd-1配體抗原的類病毒粒子 |
| TWI720946B (zh) | 2014-08-08 | 2021-03-11 | 美商Vlp醫療股份有限公司 | 包含改質套膜蛋白質e3之類病毒粒子 |
| EP3177640B1 (en) * | 2014-08-08 | 2020-05-06 | The Board of Trustees of the Leland Stanford Junior University | High affinity pd-1 agents and methods of use |
| CA2971734C (en) * | 2014-12-22 | 2025-11-18 | Pd-1 Acquisition Group, Llc | Anti-pd-1 antibodies |
-
2018
- 2018-03-28 CN CN201880022159.XA patent/CN110636855B/zh active Active
- 2018-03-28 CA CA3058393A patent/CA3058393A1/en active Pending
- 2018-03-28 CN CN202410999144.6A patent/CN118909082A/zh active Pending
- 2018-03-28 US US16/498,929 patent/US11684660B2/en active Active
- 2018-03-28 ES ES18778305T patent/ES2963635T3/es active Active
- 2018-03-28 KR KR1020197031158A patent/KR102653567B1/ko active Active
- 2018-03-28 RU RU2019131252A patent/RU2019131252A/ru unknown
- 2018-03-28 BR BR112019020386-9A patent/BR112019020386A2/pt active Search and Examination
- 2018-03-28 WO PCT/US2018/024831 patent/WO2018183488A1/en not_active Ceased
- 2018-03-28 EP EP18778305.5A patent/EP3600398B1/en active Active
- 2018-03-28 AU AU2018243920A patent/AU2018243920B2/en active Active
- 2018-03-28 JP JP2019553504A patent/JP7346302B2/ja active Active
-
2025
- 2025-03-11 AU AU2025201760A patent/AU2025201760A1/en active Pending